Robert J DeVita[Author] - Search Results

Year	Number of Results
2003	1
2004	2
2006	2
2007	4
2008	1
2009	3
2010	4
2011	1
2013	4
2014	3
2015	1
2016	1
2017	1
2018	3
2019	4
2020	6
2021	7
2022	1
2023	2
2024	4

1

IUPAC-Richter Prize Call for Nominations.

Fischer J, Ali A, DeVita RJ. Fischer J, et al. Among authors: devita rj. J Med Chem. 2021 Oct 14;64(19):13937. doi: 10.1021/acs.jmedchem.1c01651. Epub 2021 Oct 4. J Med Chem. 2021. PMID: 34606261 No abstract available.

2

DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.

Kumar K, Suebsuwong C, Wang P, Garcia-Ocana A, Stewart AF, DeVita RJ. Kumar K, et al. Among authors: devita rj. J Med Chem. 2021 Mar 25;64(6):2901-2922. doi: 10.1021/acs.jmedchem.0c02050. Epub 2021 Mar 8. J Med Chem. 2021. PMID: 33682417 Review.

3

Monoubiquitination empowers ubiquitin chain elongation.

Wu K, DeVita RJ, Pan ZQ. Wu K, et al. Among authors: devita rj. J Biol Chem. 2024 Mar;300(3):105753. doi: 10.1016/j.jbc.2024.105753. Epub 2024 Feb 13. J Biol Chem. 2024. PMID: 38354782 Free PMC article.

4

Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.

Leandro J, Khamrui S, Suebsuwong C, Chen PJ, Secor C, Dodatko T, Yu C, Sanchez R, DeVita RJ, Houten SM, Lazarus MB. Leandro J, et al. Among authors: devita rj. Open Biol. 2022 Sep;12(9):220179. doi: 10.1098/rsob.220179. Epub 2022 Sep 21. Open Biol. 2022. PMID: 36128717 Free PMC article.

5

Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges.

Wang P, Karakose E, Choleva L, Kumar K, DeVita RJ, Garcia-Ocaña A, Stewart AF. Wang P, et al. Among authors: devita rj. Front Endocrinol (Lausanne). 2021 Jul 16;12:671946. doi: 10.3389/fendo.2021.671946. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34335466 Free PMC article. Review.

6

Acyl-CoA dehydrogenase substrate promiscuity: Challenges and opportunities for development of substrate reduction therapy in disorders of valine and isoleucine metabolism.

Houten SM, Dodatko T, Dwyer W, Violante S, Chen H, Stauffer B, DeVita RJ, Vaz FM, Cross JR, Yu C, Leandro J. Houten SM, et al. Among authors: devita rj. J Inherit Metab Dis. 2023 Sep;46(5):931-942. doi: 10.1002/jimd.12642. Epub 2023 Jun 19. J Inherit Metab Dis. 2023. PMID: 37309295

7

Tetrahydroindolizinone NK1 antagonists.

Bao J, Lu H, Morriello GJ, Carlson EJ, Wheeldon A, Chicchi GG, Kurtz MM, Tsao KL, Zheng S, Tong X, Mills SG, DeVita RJ. Bao J, et al. Among authors: devita rj. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2354-8. doi: 10.1016/j.bmcl.2010.01.120. Epub 2010 Feb 1. Bioorg Med Chem Lett. 2010. PMID: 20188553

8

CRL4b Inhibition Ameliorates Experimental Autoimmune Encephalomyelitis Progression.

Dar AA, Ortega Y, Aktas S, Wu K, Guha I, Porter N, Rosen S, DeVita RJ, Pan ZQ, Oliver PM. Dar AA, et al. Among authors: devita rj. J Immunol. 2024 Mar 15;212(6):982-991. doi: 10.4049/jimmunol.2300754. J Immunol. 2024. PMID: 38265261

9

Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors.

DeVita RJ, Pinto S. DeVita RJ, et al. J Med Chem. 2013 Dec 27;56(24):9820-5. doi: 10.1021/jm4007033. Epub 2013 Sep 3. J Med Chem. 2013. PMID: 23919406 Review.

10

Encounter and React: Computer-Guided Design of Covalent Inhibitors.

Ung PM, DeVita RJ, Schlessinger A. Ung PM, et al. Among authors: devita rj. Cell Chem Biol. 2019 Jan 17;26(1):6-8. doi: 10.1016/j.chembiol.2018.12.009. Cell Chem Biol. 2019. PMID: 30658111 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year